- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04214262
Tester tillegget av stoffet Atezolizumab til den vanlige strålebehandlingen for pasienter med tidlig ikke-småcellet lungekreft
En randomisert fase III-studie av induksjon/konsolidering atezolizumab (NSC #783608) + SBRT versus SBRT alene i høyrisiko, tidlig stadium NSCLC
This phase III trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy, such as stereotactic body radiation therapy, uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving atezolizumab and radiation therapy may work better than radiation therapy alone in treating patients with early non-small cell lung cancer.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
PRIMARY OBJECTIVE:
I. To compare overall survival (OS) in patients with inoperable, early stage non-small cell lung cancer (NSCLC) randomized to stereotactic body radiation therapy (SBRT) with or without atezolizumab.
SECONDARY OBJECTIVES:
I. To compare investigator-assessed progression-free survival (IA-PFS) between the arms.
II. To compare progression free survival (PFS) by blinded independent centralized review (BIRC) between the arms in a random subset of patients.
III. To evaluate distant, locoregional, and local failure rates within each treatment arm.
IV. To evaluate the frequency and severity of toxicities within each treatment arm.
ADDITIONAL OBJECTIVE:
I. To collect specimens for banking.
HEALTH-RELATED QUALITY OF LIFE (HRQOL) OBJECTIVE:
I. This objective will not be met, as the study was closed following the first interim analysis.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A: Patients receive atezolizumab intravenously (IV) over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for 8 cycles in the absence of disease progression or unacceptable toxicity. Starting on day 1 cycle 3, patients also undergo SBRT for 3-8 treatments every 2 days or once daily (QD) over 1-3 weeks. Patients undergo fludeoxyglucose F-18 (FDG)-positron emission tomography/computed tomography (PET/CT) during screening. Patients undergo blood sample collection and CT scans throughout the trial.
ARM B: Beginning 21 days after randomization, patients undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks. Patients undergo FDG-PET/CT during screening. Patients undergo blood sample collection and CT scans throughout the trial.
After completion of study treatment, patients are followed for 5 years after randomization.
Studietype
Registrering (Faktiske)
Fase
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
Alaska
-
Anchorage, Alaska, Forente stater, 99508
- Providence Alaska Medical Center
-
-
Arkansas
-
Jonesboro, Arkansas, Forente stater, 72401
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
-
Little Rock, Arkansas, Forente stater, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Antioch, California, Forente stater, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Bakersfield, California, Forente stater, 93301
- AIS Cancer Center at San Joaquin Community Hospital
-
Berkeley, California, Forente stater, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Beverly Hills, California, Forente stater, 90211
- Tower Cancer Research Foundation
-
Dublin, California, Forente stater, 94568
- Kaiser Permanente Dublin
-
Fremont, California, Forente stater, 94538
- Kaiser Permanente-Fremont
-
Fresno, California, Forente stater, 93720
- Kaiser Permanente-Fresno
-
Loma Linda, California, Forente stater, 92354
- Loma Linda University Medical Center
-
Loma Linda, California, Forente stater, 92357
- Veterans Affairs Loma Linda Healthcare System
-
Long Beach, California, Forente stater, 90822
- Tibor Rubin VA Medical Center
-
Los Angeles, California, Forente stater, 90033
- USC / Norris Comprehensive Cancer Center
-
Los Angeles, California, Forente stater, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Forente stater, 90033
- Los Angeles General Medical Center
-
Marysville, California, Forente stater, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, Forente stater, 95355
- Memorial Medical Center
-
Modesto, California, Forente stater, 95356
- Kaiser Permanente-Modesto
-
Oakland, California, Forente stater, 94611
- Kaiser Permanente-Oakland
-
Orange, California, Forente stater, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, Forente stater, 92868
- Saint Joseph Hospital - Orange
-
Palm Springs, California, Forente stater, 92262
- Desert Regional Medical Center
-
Richmond, California, Forente stater, 94801
- Kaiser Permanente-Richmond
-
Roseville, California, Forente stater, 95678
- The Permanente Medical Group-Roseville Radiation Oncology
-
Roseville, California, Forente stater, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, Forente stater, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Roseville, California, Forente stater, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Forente stater, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Forente stater, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, Forente stater, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, Forente stater, 95823
- Kaiser Permanente-South Sacramento
-
San Francisco, California, Forente stater, 94121
- Veterans Affairs Medical Center - San Francisco
-
San Francisco, California, Forente stater, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Forente stater, 94115
- California Pacific Medical Center-Pacific Campus
-
San Jose, California, Forente stater, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, Forente stater, 94577
- Kaiser Permanente San Leandro
-
San Rafael, California, Forente stater, 94903
- Kaiser San Rafael-Gallinas
-
Santa Clara, California, Forente stater, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Forente stater, 95403
- Kaiser Permanente-Santa Rosa
-
South San Francisco, California, Forente stater, 94080
- Kaiser Permanente Cancer Treatment Center
-
South San Francisco, California, Forente stater, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, Forente stater, 95210
- Kaiser Permanente-Stockton
-
Truckee, California, Forente stater, 96161
- Gene Upshaw Memorial Tahoe Forest Cancer Center
-
Vacaville, California, Forente stater, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Forente stater, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Forente stater, 94589
- Sutter Solano Medical Center/Cancer Center
-
Walnut Creek, California, Forente stater, 94596
- Kaiser Permanente-Walnut Creek
-
Whittier, California, Forente stater, 90602
- Presbyterian Intercommunity Hospital
-
-
Colorado
-
Aurora, Colorado, Forente stater, 80045
- Rocky Mountain Regional VA Medical Center
-
Aurora, Colorado, Forente stater, 80045
- UCHealth University of Colorado Hospital
-
Colorado Springs, Colorado, Forente stater, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, Forente stater, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, Forente stater, 80920
- Memorial Hospital North
-
Denver, Colorado, Forente stater, 80205
- Kaiser Permanente-Franklin
-
Fort Collins, Colorado, Forente stater, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, Forente stater, 80528
- Cancer Care and Hematology-Fort Collins
-
Greeley, Colorado, Forente stater, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, Forente stater, 80631
- Banner North Colorado Medical Center
-
Highlands Ranch, Colorado, Forente stater, 80129
- UCHealth Highlands Ranch Hospital
-
Lafayette, Colorado, Forente stater, 80026
- Kaiser Permanente-Rock Creek
-
Lone Tree, Colorado, Forente stater, 80124
- Kaiser Permanente-Lone Tree
-
Loveland, Colorado, Forente stater, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, Forente stater, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
-
Connecticut
-
Fairfield, Connecticut, Forente stater, 06824
- Smilow Cancer Hospital Care Center-Fairfield
-
Greenwich, Connecticut, Forente stater, 06830
- Smilow Cancer Hospital Care Center at Greenwich
-
Guilford, Connecticut, Forente stater, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hamden, Connecticut, Forente stater, 06518
- Smilow Cancer Hospital-Hamden Care Center
-
New Haven, Connecticut, Forente stater, 06520
- Yale University
-
North Haven, Connecticut, Forente stater, 06473
- Yale-New Haven Hospital North Haven Medical Center
-
Trumbull, Connecticut, Forente stater, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterford, Connecticut, Forente stater, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Dover, Delaware, Forente stater, 19901
- Bayhealth Hospital Kent Campus
-
Millville, Delaware, Forente stater, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, Forente stater, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Forente stater, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, Forente stater, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20037
- George Washington University Medical Center
-
-
Florida
-
Aventura, Florida, Forente stater, 33180
- GenesisCare USA - Aventura FP
-
Aventura, Florida, Forente stater, 33180
- GenesisCare USA - Aventura
-
Jupiter, Florida, Forente stater, 33458
- Jupiter Medical Center
-
Orlando, Florida, Forente stater, 32806
- Orlando Health Cancer Institute
-
Pembroke Pines, Florida, Forente stater, 33028
- Memorial Hospital West
-
Plantation, Florida, Forente stater, 33324
- GenesisCare USA - Plantation
-
Sarasota, Florida, Forente stater, 34239
- Sarasota Memorial Hospital
-
Sarasota, Florida, Forente stater, 34232
- Florida Cancer Specialists - Sarasota
-
Sarasota, Florida, Forente stater, 34243
- Sarasota Memorial Health Care Center at University Parkway
-
Sarasota, Florida, Forente stater, 34239
- Florida Cancer Specialists - Sarasota Downtown
-
-
Georgia
-
Augusta, Georgia, Forente stater, 30912
- Augusta University Medical Center
-
Augusta, Georgia, Forente stater, 30901
- Augusta Oncology Associates PC-D'Antignac
-
Savannah, Georgia, Forente stater, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Savannah, Georgia, Forente stater, 31404
- Memorial Health University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Forente stater, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Forente stater, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, Forente stater, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Forente stater, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, Forente stater, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Forente stater, 96817
- Queen's Cancer Center - Kuakini
-
‘Aiea, Hawaii, Forente stater, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Forente stater, 96701
- Pali Momi Medical Center
-
-
Idaho
-
Boise, Idaho, Forente stater, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Caldwell, Idaho, Forente stater, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Nampa, Idaho, Forente stater, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
-
Illinois
-
Aurora, Illinois, Forente stater, 60504
- Rush-Copley Medical Center
-
Bloomington, Illinois, Forente stater, 61704
- Illinois CancerCare-Bloomington
-
Bloomington, Illinois, Forente stater, 61701
- OSF Saint Joseph Medical Center
-
Canton, Illinois, Forente stater, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Forente stater, 62321
- Illinois CancerCare-Carthage
-
Chicago, Illinois, Forente stater, 60612
- University of Illinois
-
Chicago, Illinois, Forente stater, 60612
- Jesse Brown Veterans Affairs Medical Center
-
Decatur, Illinois, Forente stater, 62526
- Decatur Memorial Hospital
-
Effingham, Illinois, Forente stater, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Forente stater, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Forente stater, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, Forente stater, 61401
- Illinois CancerCare-Galesburg
-
Kewanee, Illinois, Forente stater, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Forente stater, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Forente stater, 60153
- Loyola University Medical Center
-
Ottawa, Illinois, Forente stater, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Forente stater, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Forente stater, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Forente stater, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Forente stater, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Forente stater, 61615
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center
-
Peru, Illinois, Forente stater, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Forente stater, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Forente stater, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, Forente stater, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Forente stater, 62702
- Springfield Clinic
-
Springfield, Illinois, Forente stater, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, Forente stater, 61801
- Carle Cancer Center
-
-
Indiana
-
Indianapolis, Indiana, Forente stater, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Forente stater, 46227
- Community Cancer Center South
-
-
Iowa
-
Ames, Iowa, Forente stater, 50010
- McFarland Clinic - Ames
-
Clive, Iowa, Forente stater, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Forente stater, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Creston, Iowa, Forente stater, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Forente stater, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Forente stater, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
West Des Moines, Iowa, Forente stater, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Wichita, Kansas, Forente stater, 67214
- Ascension Via Christi Hospitals Wichita
-
-
Kentucky
-
Lexington, Kentucky, Forente stater, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
-
Louisiana
-
Baton Rouge, Louisiana, Forente stater, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, Forente stater, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, Forente stater, 70809
- Mary Bird Perkins Cancer Center
-
Baton Rouge, Louisiana, Forente stater, 70808
- Our Lady of the Lake Physician Group
-
Houma, Louisiana, Forente stater, 70360
- Mary Bird Perkins Cancer Center - Houma
-
Houma, Louisiana, Forente stater, 70360
- Terrebonne General Medical Center
-
Metairie, Louisiana, Forente stater, 70006
- East Jefferson General Hospital
-
-
Maryland
-
Towson, Maryland, Forente stater, 21204
- UM Saint Joseph Medical Center
-
-
Massachusetts
-
Beverly, Massachusetts, Forente stater, 01915
- Beverly Hospital
-
Burlington, Massachusetts, Forente stater, 01805
- Lahey Clinic
-
Gloucester, Massachusetts, Forente stater, 01930
- Addison Gilbert Hospital
-
Winchester, Massachusetts, Forente stater, 01890
- Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
-
-
Michigan
-
Ann Arbor, Michigan, Forente stater, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Brighton, Michigan, Forente stater, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Forente stater, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, Forente stater, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Forente stater, 48346
- Michigan Healthcare Professionals Clarkston
-
Dearborn, Michigan, Forente stater, 48124
- Corewell Health Dearborn Hospital
-
Detroit, Michigan, Forente stater, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Forente stater, 48236
- Henry Ford Health Saint John Hospital
-
Farmington Hills, Michigan, Forente stater, 48334
- Michigan Healthcare Professionals Farmington
-
Farmington Hills, Michigan, Forente stater, 48336
- Corewell Health Farmington Hills Hospital
-
Flint, Michigan, Forente stater, 48503
- Genesys Hurley Cancer Institute
-
Kalamazoo, Michigan, Forente stater, 49007
- West Michigan Cancer Center
-
Lansing, Michigan, Forente stater, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Forente stater, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Macomb, Michigan, Forente stater, 48044
- Michigan Healthcare Professionals Macomb
-
Niles, Michigan, Forente stater, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Novi, Michigan, Forente stater, 48374
- Henry Ford Health Providence Novi Hospital
-
Pontiac, Michigan, Forente stater, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Forente stater, 48341
- Michigan Healthcare Professionals Pontiac
-
Royal Oak, Michigan, Forente stater, 48073
- Corewell Health William Beaumont University Hospital
-
Saginaw, Michigan, Forente stater, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Forente stater, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, Forente stater, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Forente stater, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Southfield, Michigan, Forente stater, 48075
- Henry Ford Health Providence Southfield Hospital
-
Tawas City, Michigan, Forente stater, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, Forente stater, 49684
- Munson Medical Center
-
Troy, Michigan, Forente stater, 48098
- Michigan Healthcare Professionals Troy
-
Troy, Michigan, Forente stater, 48085
- Corewell Health Beaumont Troy Hospital
-
Warren, Michigan, Forente stater, 48093
- Henry Ford Health Warren Hospital
-
West Branch, Michigan, Forente stater, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, Forente stater, 49519
- University of Michigan Health - West
-
-
Minnesota
-
Bemidji, Minnesota, Forente stater, 56601
- Sanford Joe Lueken Cancer Center
-
Duluth, Minnesota, Forente stater, 55805
- Miller-Dwan Hospital
-
Minneapolis, Minnesota, Forente stater, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Forente stater, 55407
- Abbott-Northwestern Hospital
-
Saint Cloud, Minnesota, Forente stater, 56303
- Coborn Cancer Center at Saint Cloud Hospital
-
Saint Louis Park, Minnesota, Forente stater, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Forente stater, 55101
- Regions Hospital
-
-
Mississippi
-
Columbus, Mississippi, Forente stater, 39705
- Baptist Memorial Hospital and Cancer Center-Golden Triangle
-
Grenada, Mississippi, Forente stater, 38901
- Baptist Cancer Center-Grenada
-
Jackson, Mississippi, Forente stater, 39216
- University of Mississippi Medical Center
-
New Albany, Mississippi, Forente stater, 38652
- Baptist Memorial Hospital and Cancer Center-Union County
-
Oxford, Mississippi, Forente stater, 38655
- Baptist Memorial Hospital and Cancer Center-Oxford
-
Southhaven, Mississippi, Forente stater, 38671
- Baptist Memorial Hospital and Cancer Center-Desoto
-
-
Missouri
-
Cape Girardeau, Missouri, Forente stater, 63703
- Saint Francis Medical Center
-
Farmington, Missouri, Forente stater, 63640
- Parkland Health Center - Farmington
-
Joplin, Missouri, Forente stater, 64804
- Freeman Health System
-
Kansas City, Missouri, Forente stater, 64128
- Kansas City Veterans Affairs Medical Center
-
Rolla, Missouri, Forente stater, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, Forente stater, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, Forente stater, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, Forente stater, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Forente stater, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Forente stater, 63131
- Missouri Baptist Medical Center
-
Sullivan, Missouri, Forente stater, 63080
- Missouri Baptist Sullivan Hospital
-
-
Montana
-
Billings, Montana, Forente stater, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, Forente stater, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Forente stater, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Forente stater, 59405
- Benefis Sletten Cancer Institute
-
-
Nebraska
-
Bellevue, Nebraska, Forente stater, 68123
- Nebraska Medicine-Bellevue
-
Grand Island, Nebraska, Forente stater, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Kearney, Nebraska, Forente stater, 68847
- CHI Health Good Samaritan
-
Omaha, Nebraska, Forente stater, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Forente stater, 68118
- Nebraska Medicine-Village Pointe
-
-
New Jersey
-
Basking Ridge, New Jersey, Forente stater, 07920
- Memorial Sloan Kettering Basking Ridge
-
Camden, New Jersey, Forente stater, 08103
- Cooper Hospital University Medical Center
-
Middletown, New Jersey, Forente stater, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, Forente stater, 07645
- Memorial Sloan Kettering Bergen
-
Pennington, New Jersey, Forente stater, 08534
- Capital Health Medical Center-Hopewell
-
Voorhees Township, New Jersey, Forente stater, 08043
- MD Anderson Cancer Center at Cooper-Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87106
- University of New Mexico Cancer Center
-
-
New York
-
Brooklyn, New York, Forente stater, 11215
- New York-Presbyterian/Brooklyn Methodist Hospital
-
Buffalo, New York, Forente stater, 14263
- Roswell Park Cancer Institute
-
Commack, New York, Forente stater, 11725
- Memorial Sloan Kettering Commack
-
Cooperstown, New York, Forente stater, 13326
- Mary Imogene Bassett Hospital
-
East Hills, New York, Forente stater, 11548
- The Cancer Institute at Saint Francis Hospital
-
Elmira, New York, Forente stater, 14905
- Arnot Ogden Medical Center/Falck Cancer Center
-
Harrison, New York, Forente stater, 10604
- Memorial Sloan Kettering Westchester
-
Lake Success, New York, Forente stater, 11042
- Northwell Health/Center for Advanced Medicine
-
New York, New York, Forente stater, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Forente stater, 10019
- Mount Sinai West
-
New York, New York, Forente stater, 10029
- Mount Sinai Hospital
-
New York, New York, Forente stater, 10011
- Mount Sinai Chelsea
-
New York, New York, Forente stater, 10075
- Lenox Hill Hospital
-
New York, New York, Forente stater, 10065
- Manhattan Eye Ear and Throat Hospital
-
Syracuse, New York, Forente stater, 13210
- State University of New York Upstate Medical University
-
The Bronx, New York, Forente stater, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, Forente stater, 10467
- Montefiore Medical Center - Moses Campus
-
Uniondale, New York, Forente stater, 11553
- Memorial Sloan Kettering Nassau
-
West Islip, New York, Forente stater, 11795
- Good Samaritan University Hospital
-
-
North Carolina
-
Asheville, North Carolina, Forente stater, 28806
- Messino Cancer Centers
-
Cary, North Carolina, Forente stater, 27518
- UNC Health Cancer Care Cary
-
Charlotte, North Carolina, Forente stater, 28204
- Novant Health Presbyterian Medical Center
-
Durham, North Carolina, Forente stater, 27705
- Durham VA Medical Center
-
Garner, North Carolina, Forente stater, 27529
- UNC Health Cancer Care Garner
-
Gastonia, North Carolina, Forente stater, 28054
- CaroMont Regional Medical Center
-
Hendersonville, North Carolina, Forente stater, 28791
- Margaret R Pardee Memorial Hospital
-
Huntersville, North Carolina, Forente stater, 28078
- Novant Health Cancer Institute - Huntersville
-
Kernersville, North Carolina, Forente stater, 27284
- Novant Health Cancer Institute - Kernersville
-
Matthews, North Carolina, Forente stater, 28105
- Novant Health Cancer Institute - Matthews
-
New Bern, North Carolina, Forente stater, 28561
- CarolinaEast Medical Center
-
Pinehurst, North Carolina, Forente stater, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Raleigh, North Carolina, Forente stater, 27607
- UNC Health Cancer Care Raleigh
-
Raleigh, North Carolina, Forente stater, 27614
- UNC Health Cancer Care Wakefield
-
Supply, North Carolina, Forente stater, 28462
- Novant Cancer Institute Radiation Oncology - Supply
-
Wilmington, North Carolina, Forente stater, 28401
- Novant Health New Hanover Regional Medical Center
-
Wilmington, North Carolina, Forente stater, 28401
- Novant Health Cancer Institute Radiation Oncology - Wilmington
-
Winston-Salem, North Carolina, Forente stater, 27103
- Novant Health Forsyth Medical Center
-
-
North Dakota
-
Bismarck, North Dakota, Forente stater, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Forente stater, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Forente stater, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Centerville, Ohio, Forente stater, 45459
- Miami Valley Hospital South
-
Chillicothe, Ohio, Forente stater, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Forente stater, 45220
- Good Samaritan Hospital - Cincinnati
-
Cleveland, Ohio, Forente stater, 44109
- MetroHealth Medical Center
-
Columbus, Ohio, Forente stater, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Forente stater, 43219
- The Mark H Zangmeister Center
-
Dayton, Ohio, Forente stater, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Forente stater, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Forente stater, 45409
- Premier Blood and Cancer Center
-
Franklin, Ohio, Forente stater, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Grove City, Ohio, Forente stater, 43123
- Mount Carmel Grove City Hospital
-
Troy, Ohio, Forente stater, 45373
- Upper Valley Medical Center
-
Westerville, Ohio, Forente stater, 43081
- Saint Ann's Hospital
-
Zanesville, Ohio, Forente stater, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Lawton, Oklahoma, Forente stater, 73505
- Cancer Centers of Southwest Oklahoma Research
-
Oklahoma City, Oklahoma, Forente stater, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Forente stater, 73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Clackamas, Oregon, Forente stater, 97015
- Clackamas Radiation Oncology Center
-
Gresham, Oregon, Forente stater, 97030
- Legacy Mount Hood Medical Center
-
Portland, Oregon, Forente stater, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, Forente stater, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Forente stater, 97225
- Providence Saint Vincent Medical Center
-
Tualatin, Oregon, Forente stater, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, Forente stater, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Danville, Pennsylvania, Forente stater, 17822
- Geisinger Medical Center
-
Drexel Hill, Pennsylvania, Forente stater, 19026
- Delaware County Memorial Hospital
-
East Stroudsburg, Pennsylvania, Forente stater, 18301
- Pocono Medical Center
-
Hershey, Pennsylvania, Forente stater, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Indiana, Pennsylvania, Forente stater, 15701
- IRMC Cancer Center
-
Lewisburg, Pennsylvania, Forente stater, 17837
- Geisinger Medical Oncology-Lewisburg
-
Monroeville, Pennsylvania, Forente stater, 15146
- UPMC Cancer Center - Monroeville
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Forente stater, 19114
- Jefferson Torresdale Hospital
-
Pittsburgh, Pennsylvania, Forente stater, 15232
- UPMC Hillman Cancer Center
-
Pittsburgh, Pennsylvania, Forente stater, 15232
- UPMC-Shadyside Hospital
-
Pittsburgh, Pennsylvania, Forente stater, 15215
- UPMC-Saint Margaret
-
Pottsville, Pennsylvania, Forente stater, 17901
- Geisinger Cancer Services-Pottsville
-
Selinsgrove, Pennsylvania, Forente stater, 17870
- Geisinger Medical Oncology-Selinsgrove
-
West Reading, Pennsylvania, Forente stater, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Forente stater, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
Willow Grove, Pennsylvania, Forente stater, 19090
- Asplundh Cancer Pavilion
-
-
Rhode Island
-
Providence, Rhode Island, Forente stater, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Bluffton, South Carolina, Forente stater, 29910
- Saint Joseph's/Candler - Bluffton Campus
-
Florence, South Carolina, Forente stater, 29506
- McLeod Regional Medical Center
-
Gaffney, South Carolina, Forente stater, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, Forente stater, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, Forente stater, 29601
- Saint Francis Hospital
-
Greer, South Carolina, Forente stater, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, Forente stater, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Sioux Falls, South Dakota, Forente stater, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Forente stater, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Collierville, Tennessee, Forente stater, 38017
- Baptist Memorial Hospital and Cancer Center-Collierville
-
Kingsport, Tennessee, Forente stater, 37660
- Ballad Health Cancer Care - Kingsport
-
Kingsport, Tennessee, Forente stater, 37660
- Wellmont Holston Valley Hospital and Medical Center
-
Memphis, Tennessee, Forente stater, 38120
- Baptist Memorial Hospital and Cancer Center-Memphis
-
-
Texas
-
Conroe, Texas, Forente stater, 77384
- UT MD Anderson - The Woodlands
-
Houston, Texas, Forente stater, 77030
- UT MD Anderson Cancer Center
-
Houston, Texas, Forente stater, 77079
- UT MD Anderson - West Houston
-
League City, Texas, Forente stater, 77573
- UT MD Anderson - League City
-
Sugar Land, Texas, Forente stater, 77478
- UT MD Anderson - Sugar Land
-
-
Utah
-
Salt Lake City, Utah, Forente stater, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Forente stater, 84148
- George E Wahlen Department of Veterans Affairs Medical Center
-
-
Virginia
-
Fairfax, Virginia, Forente stater, 22031
- Inova Schar Cancer Institute
-
Fishersville, Virginia, Forente stater, 22939
- Augusta Health Center for Cancer and Blood Disorders
-
Norton, Virginia, Forente stater, 24273
- Ballad Health Cancer Care - Norton
-
-
Washington
-
Seattle, Washington, Forente stater, 98101
- Virginia Mason Medical Center
-
Vancouver, Washington, Forente stater, 98686
- Legacy Salmon Creek Hospital
-
Vancouver, Washington, Forente stater, 98684
- Legacy Cancer Institute Medical Oncology and Day Treatment
-
-
West Virginia
-
Charleston, West Virginia, Forente stater, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
Huntington, West Virginia, Forente stater, 25701
- Edwards Comprehensive Cancer Center
-
Wheeling, West Virginia, Forente stater, 26003
- Wheeling Hospital/Schiffler Cancer Center
-
-
Wisconsin
-
Antigo, Wisconsin, Forente stater, 54409
- Aspirus Cancer Care-Antigo-Volm Cancer Center
-
Appleton, Wisconsin, Forente stater, 54911
- ThedaCare Regional Cancer Center
-
Appleton, Wisconsin, Forente stater, 54915
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
-
Ashland, Wisconsin, Forente stater, 54806
- Northwest Wisconsin Cancer Center
-
Brookfield, Wisconsin, Forente stater, 53045
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
-
Burlington, Wisconsin, Forente stater, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chilton, Wisconsin, Forente stater, 53014
- Ascension Calumet Hospital-Chilton
-
Eau Claire, Wisconsin, Forente stater, 54701
- Marshfield Medical Center-EC Cancer Center
-
Eau Claire, Wisconsin, Forente stater, 54701
- HSHS Sacred Heart Hospital
-
Franklin, Wisconsin, Forente stater, 53132
- Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
-
Germantown, Wisconsin, Forente stater, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, Forente stater, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, Forente stater, 54311
- Aurora BayCare Medical Center
-
Green Bay, Wisconsin, Forente stater, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Forente stater, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay, Wisconsin, Forente stater, 54301
- Bellin Memorial Hospital
-
Kenosha, Wisconsin, Forente stater, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, Forente stater, 54601
- Gundersen Lutheran Medical Center
-
La Crosse, Wisconsin, Forente stater, 54601
- Mayo Clinic Health System-Franciscan Healthcare
-
Madison, Wisconsin, Forente stater, 53705
- William S Middleton VA Medical Center
-
Madison, Wisconsin, Forente stater, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Marinette, Wisconsin, Forente stater, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marshfield, Wisconsin, Forente stater, 54449
- Marshfield Medical Center-Marshfield
-
Medford, Wisconsin, Forente stater, 54451
- Aspirus Medford Hospital
-
Mequon, Wisconsin, Forente stater, 53097
- Ascension Columbia Saint Mary's Hospital-Ozaukee Campus-Mequon
-
Milwaukee, Wisconsin, Forente stater, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, Forente stater, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, Forente stater, 53233
- Aurora Sinai Medical Center
-
Milwaukee, Wisconsin, Forente stater, 53211
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus
-
Minocqua, Wisconsin, Forente stater, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Forente stater, 53149
- ProHealth D N Greenwald Center
-
New London, Wisconsin, Forente stater, 54961
- ThedaCare Cancer Care - New London
-
Oconomowoc, Wisconsin, Forente stater, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oshkosh, Wisconsin, Forente stater, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Oshkosh, Wisconsin, Forente stater, 54904
- Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
-
Racine, Wisconsin, Forente stater, 53406
- Aurora Cancer Care-Racine
-
Racine, Wisconsin, Forente stater, 53405
- Ascension All Saints Hospital-Spring Street-Racine
-
Rhinelander, Wisconsin, Forente stater, 54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Rice Lake, Wisconsin, Forente stater, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, Forente stater, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Sheboygan, Wisconsin, Forente stater, 53081
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Stevens Point, Wisconsin, Forente stater, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Stevens Point, Wisconsin, Forente stater, 54481
- Aspirus Cancer Care - Stevens Point
-
Sturgeon Bay, Wisconsin, Forente stater, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Summit, Wisconsin, Forente stater, 53066
- Aurora Medical Center in Summit
-
Two Rivers, Wisconsin, Forente stater, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha, Wisconsin, Forente stater, 53188
- UW Cancer Center at ProHealth Care
-
Wausau, Wisconsin, Forente stater, 54401
- Aspirus Cancer Care-Wausau
-
Wauwatosa, Wisconsin, Forente stater, 53226
- Aurora Cancer Care-Milwaukee West
-
Wauwatosa, Wisconsin, Forente stater, 53226
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
-
West Allis, Wisconsin, Forente stater, 53227
- Aurora West Allis Medical Center
-
Weston, Wisconsin, Forente stater, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, Forente stater, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
-
Patient must have histologically or cytologically proven stage I-IIA or limited T3N0M0 non-small cell lung cancer (NSCLC), without radiographic evidence of nodal or distant involvement (N0M0). Patient may have T3 disease with the exclusion of pericardial involvement. Patients with multifocal tumors with no more than two lesions confirmed or suspected to be synchronous early stage NSCLCs are eligible provided at least one lesion is histologically or cytologically proven to be NSCLC and meets one or more high-risk features
-
Disease must have one or more of the following high-risk features:
- Tumor diameter >= 2 cm (inclusive of any non-solid, ground glass component) as assessed by diagnostic CT
- Tumor standard uptake value (SUV) max >= 6.2 as assessed by FDG PET/CT
- Moderately differentiated, poorly differentiated, or undifferentiated histology
-
Patient must have undergone diagnostic chest CT with or without contrast (IV contrast preferred) within 42 days prior to randomization. PET-CT may be used if the CT portion is of comparable diagnostic quality to a stand-alone CT. All disease must be assessed within 42 days prior to randomization
-
Patient must have undergone FDG PET/CT of chest within 90 days prior to randomization
-
Patient must not have evidence of hilar or mediastinal nodal involvement. Any patient with radiographically suspicious hilar or mediastinal nodes (including features such as non-calcified nodes with a short axis diameter > 1 cm, abnormal morphology, and/or elevated FDG avidity) must undergo cytologic sampling of suspicious nodes to rule out involvement prior to randomization. Mediastinal nodal sampling for other patients is optional. For cases in which the treating physician/multidisciplinary opinion is used to define nodes as "non-suspicious" (such as long-standing, stable enlarged nodes from other medical causes), the rationale must be clearly documented within the medical record
-
Patient must have undergone history and physical examination within 28 days prior to randomization
-
Patient must be medically or surgically inoperable as documented by the evaluating thoracic surgeon or multi-disciplinary tumor board consensus OR patient's unwillingness to undergo surgical resection must be clearly documented
-
Patient must not have received any prior treatment for the current NSCLC diagnosis
-
Patient must not have undergone prior radiation to overlapping regions of the chest that, in the opinion of the treatment physician, will interfere with protocol treatment
-
Patient must not have received treatment with systemic immunostimulatory or immunosuppressive agents, including corticosteroids, within 14 days prior to randomization
-
Patient must be >= 18 years old
-
Patient must have Zubrod performance status of 0-2
-
Patient must have adequate liver function defined as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x institutional upper level of normal (IULN) within 28 days prior to randomization
-
Patient must have adequate renal function defined as calculated creatinine clearance >= 30 mL/min using the following formula. The serum creatinine value used in the calculation must have been collected within 28 days prior to randomization
-
Patient must have absolute neutrophil count (ANC), platelets, and hemoglobin measured within 28 days prior to randomization. The purpose of these tests is to collect baseline values to compare with on-treatment values
-
Patient must have thyroid-stimulating hormone (TSH) measured within 28 days prior to randomization. The purpose of this test is to collect baseline values to compare with on-treatment values
-
Patient must not have significant cardiovascular disease (New York Heart Association [NYHA] class II or greater)
-
Patient must not have myocardial infarction within 90 days prior to randomization
-
Patient must not have unstable arrhythmias or unstable angina
-
Patient must not have known left ventricular ejection fraction (LVEF) < 40% within 28 days prior to randomization
- NOTE: Assessment of LVEF by echocardiogram or multigated acquisition (MUGA) is not an eligibility requirement, but if a standard of care echocardiogram or MUGA was clinically indicated, the LVEF must not be < 40% within 28 days prior to randomization
-
Patient must not have had an infection >= grade 3 (Common Terminology Criteria for Adverse Events [CTCAE] version 5.0) within 28 days prior to randomization
-
Patient must not have an active autoimmune disease that has required systemic treatment in past two years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered a form of systemic treatment and is allowed
-
Patient must be tested for hepatitis B within 28 days prior to randomization. Patient must not have active (chronic or acute) hepatitis B virus (HBV) infection. Patients may have past or resolved HBV infection
- Active HBV is defined as having a positive hepatitis B surface antigen (HBsAg) test
- Past or resolved HBV is defined as having a negative HBsAG test and a positive total hepatitis B core antibody (HBcAb) test
-
Patient must be tested for hepatitis C within 28 days prior to randomization. Patient must not have active hepatitis C virus (HCV) infection
- Active HCV is defined as having a positive HCV antibody test followed by a positive HCV ribonucleic acid (RNA) test
-
Patient must have pulmonary function testing to include, at a minimum, forced expiratory volume in 1 second (FEV1) and Diffusing capability of carbon monoxide (DLCO) documented within 90 days prior to randomization
-
Patients with known human immunodeficiency virus (HIV) infection must be receiving anti-retroviral therapy and have an undetectable viral load at their most recent viral load test within 6 months prior to randomization
-
Patient must not have a history of clinically significant interstitial lung disease or evidence of active pneumonitis on the screening chest CT
-
Patients must not have a prior or concurrent malignancy whose natural history or treatment has the potential (in the opinion of the treating physician) to interfere with the safety or efficacy assessment of the investigational regimen
-
Patients must not be pregnant due to the potential teratogenic side effects of the protocol treatment. Women of reproductive potential and men must have agreed to use an effective contraception method for the duration of protocol treatment, and for 5 months (150 days) after the last dose of atezolizumab. A woman is considered to be of "reproductive potential" if she has had a menses at any time in the preceding 12 consecutive months. In addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation. However, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with atezolizumab, breastfeeding must be discontinued prior to randomization
-
Patients of reproductive potential must have a negative serum pregnancy test within 14 days prior to randomization
-
Patients must not have known active tuberculosis
-
Patients must not have received a live, attenuated vaccine within 28 days prior to randomization
- NOTE: All coronavirus disease 2019 (COVID-19) vaccines that have received Food and Drug Administration (FDA) approval or FDA emergency use authorization are acceptable
-
Patients must not have a known history of allergic reactions attributed to compounds of similar chemical or biologic composition to atezolizumab
-
Patients must not have a known history of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric antibodies, fusion proteins, or Chinese hamster ovary cell products or to any component of the atezolizumab formulation
-
Patient must agree to have specimens submitted for translational medicine and banking
-
Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
-
As a part of the OPEN registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
-
Patients who can complete quality of life instruments in English, French, or Spanish must agree to complete the questionnaires at the protocol-specified time points
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Arm A (atezolizumab, SBRT)
Patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for 8 cycles in the absence of disease progression or unacceptable toxicity. Starting on day 1 cycle 3, patients also undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks. Patients undergo FDG-PET/CT during screening. Patients undergo blood sample collection and CT scans throughout the trial. |
Ancillary studies
Andre navn:
Undergo blood sample collection
Andre navn:
Ancillary studies Undergo CT or PET/CT
Andre navn:
Undergo PET/CT
Andre navn:
Given IV
Andre navn:
Undergo FDG PET/CT
Andre navn:
Undergo SBRT
Andre navn:
|
|
Aktiv komparator: Arm B (SBRT)
Beginning 21 days after randomization, patients undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks. Patients undergo FDG-PET/CT during screening. Patients undergo blood sample collection and CT scans throughout the trial. |
Ancillary studies
Andre navn:
Undergo blood sample collection
Andre navn:
Ancillary studies Undergo CT or PET/CT
Andre navn:
Undergo PET/CT
Andre navn:
Undergo FDG PET/CT
Andre navn:
Undergo SBRT
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall Survival
Tidsramme: From date of registration up to two years
|
Count of participants who have died, measured at two years from trial registration. |
From date of registration up to two years
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of Adverse Events
Tidsramme: Up to 5 years after registration
|
Only adverse events that are possibly, probably or definitely related to study drug are reported. |
Up to 5 years after registration
|
|
IA-PFS
Tidsramme: From registration up to 5 years
|
Compare investigator-assessed progression-free survival (IA-PFS) between the arms. IA-PFS is defined as 20% increase in the longest diameter of the primary lung tumor over smallest measurement observed using the same techniques as baseline, as well as an absolute increase of at least 0.5 cm, accompanied by confirmatory study (unequivocal PET findings or biopsy) OR appearance of any new lesion/site OR death due to disease without prior documentation of progression OR unequivocal PET findings and/or biopsy confirming malignancy in the absence of growth. |
From registration up to 5 years
|
|
Progression Free Survival
Tidsramme: Up to 5 years from registration
|
Compare PFS (progression free survival) by blinded independent centralized review (BIRC) between the arms in a random subset of patients. PFS is defined as time from date of randomization to date of first documentation of progression assessed by BICR, or death due to any cause. PFS-BICR-1 for patients last known to be alive without report of progression are censored at date of last disease assessment. For patients with a missing scan (or consecutive missing scans) whose subsequent scan determines progression, the expected date of the first missing scan (as defined by the disease assessment schedule) will be used as the date of progression. |
Up to 5 years from registration
|
|
Distant, Locoregional, Local Failure Rates.
Tidsramme: Up to 5 years from registration
|
Evaluate distant, locoregional, and local failure rates within each treatment arm. Treatment failure is defined as time from date of randomization to date of first documentation of investigator-assessed progression or symptomatic deterioration (as defined above), early discontinuation of treatment, or death due to any cause. Time to treatment failure for patients last known not to have failed treatment are censored at the date of last contact. |
Up to 5 years from registration
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Megan E Daly, SWOG Cancer Research Network
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Neoplasmer etter nettsted
- Neoplasmer
- Sykdommer i luftveiene
- Lungesykdommer
- Neoplasmer i luftveiene
- Thoracale neoplasmer
- Karsinom, bronkogent
- Bronkiale neoplasmer
- Lungeneoplasmer
- Karsinom, ikke-småcellet lunge
- Undersøkelsesteknikker
- Terapeutikk
- Kliniske laboratorieteknikker
- Diagnostiske teknikker og prosedyrer
- Diagnose
- Kirurgiske prosedyrer, operativ
- Karbohydrater
- Kjemisteknikker, analytisk
- Spektrumanalyse
- Strålebehandling
- Stereotaksiske teknikker
- Nevrokirurgiske prosedyrer
- Deoxyglucose
- Deoxy -sukker
- Fluorodeoksyglukose F18
- Prøvehåndtering
- Magnetisk resonansspektroskopi
- Radiokirurgi
- Atezolizumab
Andre studie-ID-numre
- NCI-2019-08627
- U10CA180888 (U.S. NIH-stipend/kontrakt)
- NCI-2019-08627 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
- S1914 (Annen identifikator: CTEP)
- S1914 (Annen identifikator: SWOG)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .